RRC is the database of papers related to the NBRP resources. Please feed back on your papers published.

Home > Detail
Reference detail
Reference Info.
Pubmed ID 21803855  
RRC ID 17604 
Author Hoellenriegel J, Meadows SA, Sivina M, Wierda WG, Kantarjian H, Keating MJ, Giese N, O'Brien S, Yu A, Miller LL, Lannutti BJ, Burger JA. 
Title The phosphoinositide 3'-kinase delta inhibitor, CAL-101, inhibits B-cell receptor signaling and chemokine networks in chronic lymphocytic leukemia. 
Journal Blood 
Published 2011-8-2 
Volume 118(13) 
Pages 3603-12 
DOI 10.1182/blood-2011-05-352492   
PII blood-2011-05-352492 
Antineoplastic Agents / therapeutic use
Cell Movement / drug effects
Cell Survival / drug effects
Cells, Cultured
Chemokines / antagonists & inhibitors*
Chemokines / metabolism
Class I Phosphatidylinositol 3-Kinases
Down-Regulation / drug effects
Drug Evaluation, Preclinical
Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy
Leukemia, Lymphocytic, Chronic, B-Cell / metabolism
Leukemia, Lymphocytic, Chronic, B-Cell / pathology*
Metabolic Networks and Pathways / drug effects
Metabolic Networks and Pathways / physiology
Phosphatidylinositol 3-Kinases / antagonists & inhibitors
Purines / pharmacology*
Purines / therapeutic use
Quinazolinones / pharmacology*
Quinazolinones / therapeutic use
Receptors, Antigen, B-Cell / antagonists & inhibitors*
Signal Transduction / drug effects
Resource Info.
Species Human and Animal Cells 
Resource name
KUSA-H1 (RCB1990) 9-15C (RCB2323

Total access count date